Sun.Dec 19, 2021

article thumbnail

Management of Chronic Low Back Pain

JAMA Internal Medicine

This Evidence to Practice review summarizes recent systematic reviews examining pharmacologic and nonpharmacologic treatments for chronic low back pain.

98
article thumbnail

Small measures can be a big help for children of mothers with depression

Scienmag

Several new studies among Syrian refugee families in Turkey and families with infants in Sweden and Bhutan show that children of mothers in poor mental health risk falling behind in their cognitive development. However, very small changes can suffice to break this correlation and enable the children to return to their normal developmental level. Having […].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Drug Channels News Roundup, December 2021: CAR-T Profits, UM Boom, Health Plans vs. Experts, Confused Physicians, and Health Insurance Explained

Drug Channels

Happy New Year, everyone! We made it through a challenging 2021. Ring in 2022 with these noisemakers from the Drug Channels party bag: Hospitals earn incredible markups on CAR-T therapies Utilization management booms Health plans often ignore clinical guidelines Benefit designs flummox physicians Plus: an awesomely concise summary of U.S. health insurance.

Drugs 81
article thumbnail

New biosensors measure toxic drugs in cancer, arthritis, and organ transplant patients

Scienmag

Researchers are a step closer to transforming a US$70 billion global diagnostic industry with new designer biosensors that ‘switch on’ colour or electrical responses to drugs used in cancer, arthritis, and organ transplant treatment. Credit: Queensland University of Technology (QUT) Researchers are a step closer to transforming a US$70 billion global diagnostic industry with new […].

Drugs 73
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

SARS-CoV-2 Antibodies After Homologous vs Heterologous Third Vaccine in Kidney Transplant Recipients

JAMA Internal Medicine

This randomized clinical trial evaluated the effectiveness of a third dose of mRNA-based vs a vector-based vaccine in 201 kidney transplant recipients with no SARS-CoV-2 antibodies after 2 prior doses of an mRNA vaccine.

article thumbnail

Wearable biosensors can help people with complex health conditions

Scienmag

Remote monitoring of health-related behaviour with wearable sensor technology is feasible for people with complex health conditions, shows a recent University of Waterloo study. “Information from wearables can provide insight into patterns of health-related behaviour and disease symptoms as they occur over days and weeks. This may be important for monitoring disease progression and the […].

69

More Trending

article thumbnail

Requirement for adults to wear masks in schools has major impact on Covid-19 transmissions, study finds

Scienmag

Adults wearing masks may decrease Covid-19 outbreaks at schools and preschools, shows a new study published in Frontiers in Public Health. The study found that the first identified cases (index cases) in schools were predominantly children, but outbreak events were more severe when an adult was the index case. Wearing a mask significantly lowered secondary […].

68
article thumbnail

New patent expiration for Bayer Hlthcare drug SAFYRAL

Drug Patent Watch

Annual Drug Patent Expirations for SAFYRAL Safyral is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are three patents…. The post New patent expiration for Bayer Hlthcare drug SAFYRAL appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Safer, newer blood thinners are under-prescribed for elderly and at-risk patients

Scienmag

Philadelphia, December 20, 2021 – Patients with atrial fibrillation are at risk of forming clots that can migrate to the brain and cause dangerous strokes; these can be prevented by chronic administration of blood-thinning drugs (anticoagulants). Introduced to the market in the past decade, direct oral anticoagulants (DOACs) are a much safer option for patients […].

article thumbnail

New patent expiration for Bayer Hlthcare drug BEYAZ

Drug Patent Watch

Annual Drug Patent Expirations for BEYAZ Beyaz is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are four patents…. The post New patent expiration for Bayer Hlthcare drug BEYAZ appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Dietary supplement use by individuals living with and beyond cancer

Scienmag

New research indicates that many individuals living with and beyond cancer use dietary supplements, often with the belief that the products will reduce the risk of cancer recurrence. Published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings reveal a need for health care professionals to provide advice and […].

article thumbnail

New patent expiration for Bayer Hlthcare drug YAZ

Drug Patent Watch

Annual Drug Patent Expirations for YAZ Yaz is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are two patents…. The post New patent expiration for Bayer Hlthcare drug YAZ appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Why do people use cannabis during pregnancy and breastfeeding?

Scienmag

People who use cannabis during pregnancy and lactation choose it to manage pregnancy-related symptoms and pre-existing conditions, such as nausea and vomiting, mental health problems, insomnia and more, according to new research published in CMAJ (Canadian Medical Association Journal). [link] Cannabis use by pregnant and breastfeeding people appears to be increasing, although there is a […].

article thumbnail

Versantis Appoints Mark Fitzpatrick, Seasoned Biotech Executive, as its New CEO

BioTech 365

Versantis Appoints Mark Fitzpatrick, Seasoned Biotech Executive, as its New CEO Versantis Appoints Mark Fitzpatrick, Seasoned Biotech Executive, as its New CEO – Versantis establishes wholly-owned U.S. subsidiary, Versantis, Inc.

52
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Gum disease increases risk of other illness such as mental health and heart conditions, study finds

Scienmag

A University of Birmingham-led study shows an increased risk of patients developing illnesses including mental ill-health and heart conditions if they have a GP-inputted medical history of periodontal (gum) disease Experts carried out a first of its kind study of the GP records of 64,379 patients who had a GP-inputted recorded history of periodontal disease, […].

article thumbnail

Vifor Pharma and American Regent announce settlement of Injectafer® patent litigation

BioTech 365

Vifor Pharma and American Regent announce settlement of Injectafer® patent litigation Vifor Pharma and American Regent announce settlement of Injectafer® patent litigation Abbreviated New Drug Application (ANDA) disputes regarding Injectafer® (ferric carboxymaltose) have now been settled ST.

Drugs 52
article thumbnail

Drug Patent Expirations for the Week of December 19, 2021

Drug Patent Watch

VOTRIENT (pazopanib hydrochloride) Novartis Patent: 7,262,203 Expiration: Dec 19, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or…. The post Drug Patent Expirations for the Week of December 19, 2021 appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40
article thumbnail

Sensorion appoints pharmaceutical industry veteran Scott D. Myers as Chairman of the Board and Independent Director

BioTech 365

Sensorion appoints pharmaceutical industry veteran Scott D. Myers as Chairman of the Board and Independent Director Sensorion appoints pharmaceutical industry veteran Scott D.

40
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Which pharmaceutical companies have the most drug patents in Switzerland?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Switzerland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Switzerland? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40
article thumbnail

Lysogene Awarded Innovation Passport by the UK MHRA for the GM1 Gangliosidosis Program

BioTech 365

Lysogene Awarded Innovation Passport by the UK MHRA for the GM1 Gangliosidosis Program Lysogene Awarded Innovation Passport by the UK MHRA for the GM1 Gangliosidosis Program First step in the recent UK MHRA initiative to accelerate the development and access … Continue reading →

article thumbnail

PerkinElmer India Welcomes Everest Instruments as its Primary, In-Country Channel Partner for Milk and Dairy Testing Solutions

BioTech 365

PerkinElmer India Welcomes Everest Instruments as its Primary, In-Country Channel Partner for Milk and Dairy Testing Solutions PerkinElmer India Welcomes Everest Instruments as its Primary, In-Country Channel Partner for Milk and Dairy Testing Solutions DELHI, India–(BUSINESS WIRE)–PerkinElmer Inc.

52
article thumbnail

Prestige BioPharma Commences Construction of Innovative Discovery Center (IDC) in Busan, Korea

BioTech 365

Prestige BioPharma Commences Construction of Innovative Discovery Center (IDC) in Busan, Korea Prestige BioPharma Commences Construction of Innovative Discovery Center (IDC) in Busan, Korea SINGAPORE–(BUSINESS WIRE)–Prestige BioPharma Limited (PBP, 950210: KRX), a Singapore-based biopharmaceutical with operations in USA and South … Continue reading →

52
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

The Chinese Red Cross Foundation Rare Disease Mutual Assistance Fund Officially Launches

BioTech 365

The Chinese Red Cross Foundation Rare Disease Mutual Assistance Fund Officially Launches The Chinese Red Cross Foundation Rare Disease Mutual Assistance Fund Officially Launches CANbridge Participated in the Ceremony as a Founding Sponsor BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc.

52
article thumbnail

FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®

BioTech 365

FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix® FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix® MELBOURNE, Australia and INDIANAPOLIS, Dec.

article thumbnail

HUTCHMED Included in FTSE Russell Indexes

BioTech 365

HUTCHMED Included in FTSE Russell Indexes HUTCHMED Included in FTSE Russell Indexes HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Dec.

40